Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

doi:10.1186/s40478-019-0837-9

Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

Acta Neuropathologica Communications

Nov 14, 2019

Dietmar Rudolf ThalJochen Walter

PMID: 31727169

DOI: 10.1186/s40478-019-0837-9

Get paper from

Abstract

Alzheimer's disease (AD)-related amyloid β-peptide (Aβ) pathology in the form of amyloid plaques and cerebral amyloid angiopathy (CAA) spreads in its topographical distribution, increases in quantity, and undergoes qualitative changes in its composition of modified Aβ species throughout...read more

Mentioned in this Paper

Alzheimer's Disease

Amyloid

Autopsy

Pathology

Positron-Emission Tomography

Amyloid beta-Peptides

Cerebral Amyloid Angiopathy

Neurofibrillary Degeneration (Morphologic Abnormality)

Disease Progression

Dementia

Paper Details

References

References
Citations

References currently unavailable
We're still populating references for this paper, please check back later.

References
Citations

No citations available
This paper may not have been cited yet.

Traumatic Encephalopathy

Traumatic Encephalopathy is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.